Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06479447 · ClinicalTrials.gov registry record · NA
Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder
A NA study of PTSD, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 17,000
- Enrollment target
- 2
- Study locations
NCT06479447: Recruiting NA study of PTSD, sponsored by University of Chicago.
NCT06479447 is a NA study of PTSD that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 17,000 participants, above the 192-participant average among 154 other PTSD trials with a reported enrollment target (8754% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06479447, a NA study of PTSD, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 17,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to implement and evaluate a more timely approach to post-traumatic stress disorder (PTSD) diagnosis and management, entitled Patient Outcome Reporting for Timely Assessments of Life with Post-Traumatic Stress Disorder (PORTAL-PTSD) in a primary care setting with a high prevalence of trauma, specifically the South Side of Chicago, in partnership with Chicago Family Health Center (CFHC).
Primary Outcome
Number and proportion of patients who were screened for PTSD, as determined by the validated Primary Care Post-Traumatic Stress Disorder screener (PC-PTSD-5).
Conditions Studied
Interventions
- OTHER PORTAL-PTSD
Study Locations (2)
Illinois
- CFHC South Chicago - Chicago
- CFHC Chicago Lawn - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,000 participants |
| Start Date | 2024-07-15 |
| Est. Completion | 2026-07-14 |
| Phase | NA |
What NCT06479447 shows while recruiting
NCT06479447 is an interventional study that assigns participants to a tested intervention. Its 17,000 participants enrollment target places it among the larger protocols in the corpus, above the 192-participant average among 154 other PTSD trials with a reported enrollment target (8754% higher).
The record links to 1 condition, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which PORTAL-PTSD is the first listed.
NCT06479447 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06479447 about?
NCT06479447 is a clinical study titled "Patient Outcome Reporting for Timely Assessments of Life With Post-Traumatic Stress Disorder". This study aims to implement and evaluate a more timely approach to post-traumatic stress disorder (PTSD) diagnosis and management, entitled Patient Outcome Reporting for Timely Assessments of Life with Post-Traumatic Stress Disorder (PORTAL-PTSD) in a primary care setting with a high prevalence of ...
What is the current status of trial NCT06479447?
This trial is currently recruiting. It is a NA study. The enrollment target is 17,000 participants. The study started on 2024-07-15. Estimated completion is 2026-07-14.
What conditions does trial NCT06479447 study?
This clinical trial studies the following conditions: PTSD.
What interventions are being tested in trial NCT06479447?
The interventions under investigation include: PORTAL-PTSD (OTHER).
Who is sponsoring clinical trial NCT06479447?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06479447 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06479447's enrollment target sits among peer trials
17,000 1st of 154 higher than 154 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06948838 · 16,895 participants · NA
Improving Hypertension Control in Safety-Net Settings: The Boston Hypertension Equity Alliance in Treatment
- NCT06245187 · 17,198 participants
Get With the Guidelines Atrial Fibrillation Registry
- NCT06951867 · 16,640 participants
Tezspire Cardiac Events PASS
- NCT06272110 · 17,500 participants
Promoting Equitable Access to Language Services in Health and Human Services
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI